Medicine and Dentistry
Infection
95%
Acinetobacter Baumannii
83%
Colistimethate
79%
Bacteremia
78%
Tigecycline
58%
Urinary Tract Infection
51%
Pathogen
39%
Healthcare Associated Infection
38%
Intensive Care Unit
37%
Mortality Rate
33%
Combination Therapy
30%
Antibiotics
26%
Pneumocystis Jirovecii
25%
Caspofungin
25%
Acute Heart Infarction
25%
Therapy Resistance
25%
Elizabethkingia Meningoseptica
25%
Disinfectant Agent
25%
Spectroscopy
25%
Chryseobacterium indologenes
25%
Salvage Therapy
25%
Lemierre's Syndrome
25%
Antibiotic Resistance
25%
Hemagglutinin
25%
Influenza Vaccine
25%
Immunogenicity
25%
Cell Culture
25%
Influenza A Virus (H7N9)
25%
Open-Label Trial
25%
Urinary Catheterization
25%
Urinary System
25%
Patient with Diabetes
25%
Delftia acidovorans
25%
Hospital Mortality
24%
Antibiogram
23%
Medical Record
20%
Sepsis
17%
Cardiac Troponin
12%
Troponin I
12%
Fomite
12%
Low Drug Dose
12%
Drug Megadose
12%
Long-Term Care
12%
Artificial Respiration
12%
Clinician
12%
Multidrug Resistance
12%
Trimethoprim/Sulfamethoxazole
12%
Prevalence
12%
Adverse Event
12%
Urine Culture
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Acinetobacter Baumannii
83%
Bacteremia
77%
Colistimethate
66%
Sepsis
54%
Urinary Tract Infection
51%
Tigecycline
44%
Infectious Agent
39%
Respiratory Tract
30%
Mortality Rate
27%
Acute Heart Infarction
25%
Nanomaterial
25%
Liquid Crystal
25%
Drug Delivery System
25%
Chlamydiae
25%
Breast Cancer
25%
Chryseobacterium indologenes
25%
Elizabethkingia Meningoseptica
25%
Healthcare Associated Infection
25%
Therapy Resistance
25%
Antibiotic Resistance
25%
Doxycycline
25%
Lemierre's Syndrome
25%
Azithromycin
25%
Hemagglutinin
25%
Normal Human
25%
Immunogenicity
25%
Influenza Vaccine
25%
Influenza A Virus (H7N9)
25%
Open-Label Trial
25%
Cell Culture
25%
Acinetobacter
25%
Delftia acidovorans
25%
Antiinfective Agent
22%
Antibiotics
20%
Hospital Mortality
18%
Randomized Controlled Trial
17%
Combination Therapy
16%
Antibiotic Agent
14%
Comorbidity
13%
Prevalence
12%
Cotrimoxazole
12%
Adverse Event
12%
Disease
12%
Microorganism
10%
Troponin I
10%
Quinolone Derivative
9%
Piperacillin Plus Tazobactam
9%
Bloodstream Infection
8%
Observational Study
8%
Immunology and Microbiology
Infectious Agent
45%
Antibiotic Sensitivity
32%
Cryptococcus neoformans
25%
Rhodotorula
25%
Trichosporon
25%
Liquid Crystal
25%
Corynebacterium striatum
25%
Chlamydiae
25%
Chryseobacterium indologenes
25%
Elizabethkingia Meningoseptica
25%
Immunocompetent Cell
25%
Influenza A Virus (H7N9)
25%
COVID-19
25%
International Classification of Diseases
25%
Normal Human
25%
Immunogenicity
25%
Colistin
25%
Influenza Vaccine
25%
Hemagglutinin
25%
Cell Culture
25%
Immunoassay
25%
Bacterial Load
25%
Immune Complex
20%
Immune Response
20%
Medline
19%
Vaccine Efficacy
14%
Chlorhexidine
12%
Surface Property
12%
Random Amplified Polymorphic DNA
12%
Mortality Rate
12%
Solution and Solubility
12%
Hemodialysis
12%
Prevalence
12%
Awareness
12%
Fomite
10%
Multidrug Resistance
10%
Titer
7%
Seroconversion
7%
down Regulation
6%
Infectious Disease
6%
Immune System
6%
Peripheral Blood Mononuclear Cell
6%
Infection Sensitivity
6%
Cochrane Library
6%
Web of Science
6%
Upregulation
6%
CD4
6%
Natural Killer Cell
6%
Chlamydia Trachomatis
6%
Comorbidity
6%